Where does Taiwan Main Orthopaedic Biotechnology Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Taiwan Main Orthopaedic Biotechnology Co., Ltd. ranks #23,501 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Taiwan Main Orthopaedic Biotechnology Co., Ltd. hold?

Taiwan Main Orthopaedic Biotechnology Co., Ltd. holds 12 US utility patents granted between 2019 and 2025, spanning 8 technology areas.

What is Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s Innovation Score?

Taiwan Main Orthopaedic Biotechnology Co., Ltd. has an Innovation Score of 33.3 out of 100 (44th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Taiwan Main Orthopaedic Biotechnology Co., Ltd. focus on?

Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 6 patents, ranking #2,680 of 7,127 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s patent grant rate increasing or decreasing?

Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s recent grant velocity is +600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s patents?

Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s patents average 5.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Taiwan Main Orthopaedic Biotechnology Co., Ltd.

Q: How is the Taiwan Main Orthopaedic Biotechnology Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 12 granted patents across 8 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Taiwan ranks #23,501 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 8 technology areas.

#23,501
of 49,997 US assignees by volume: 44th percentile
by Innovation Score (33.3/100): 5.6
avg claims per patent: +600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23501 · Foreign Corporation #23,501 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,501/49,997
PHOTO-FINISH Synecor
CPC-NARROW A61B · 8 areas
INNOV-THIN 33.3/100
CLAIMS-SPARSE 5.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Synecor LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Taiwan’s 33.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (27%) Velocity 11.1 pts (33%) Breadth 10.0 pts (30%) Claim depth 3.3 pts (10%)

Qualcomm Incorporated · highest

85
Taiwan Main… · this assignee

33
3D Lighting… · lowest

7

What this shows Taiwan's Innovation Score is 33.3/100 (44th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Taiwan?

Each dot is one of Taiwan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Taiwan’s own 5.6 claims/patent is at or below the 9.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Taiwan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Taiwan's grants concentrate

Taiwan Main Orthopaedic Biotechnology Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 50% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2019. By volume, Taiwan sits between Synecor LLC and Technische UNIVERSITÄT Dortmund.

Taiwan's three-year grant acceleration

Taiwan Main Orthopaedic Biotechnology Co., Ltd. shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Synecor

12
Synthomer Adhesive

12
Taiko Pharmaceuti…

12
Taiwan Alpha

12
TAK Logic

12
TBK

12
TCL AIR Condition…

12
Technische Univer…

12
Taiwan Main Ortho… ◀

12

What this shows Taiwan holds 12 patents at rank #23,490, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Taiwan

By rank, the assignees closest to #23,490 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Taiwan's primary technology class.

Taiwan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 44th percentile higher than 44% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Taiwan Main Orthopaedic Biotechnology Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	8.3%
2020	2	16.7%
2022	4	33.3%
2024	1	8.3%
2025partial year	4	33.3%

Which technologies does Taiwan Main Orthopaedic Biotechnology Co., Ltd. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 6

G06T - Image Data Processing OR Generation, IN General 6

G02B - Optical Elements, Systems OR Apparatus 4

G06F - Electric Digital Data Processing 2

G06V - Image OR Video Recognition OR Understanding 2

H04N - Pictorial Communication, e.g. Television 2

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s patent record in context - here's where to go next.

Taiwan Main Orthopaedic Biotechnology Co., Ltd.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 50% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #23,501 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Taiwan Main Orthopaedic Biotechnology Co., Ltd. against Synecor LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.